Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jun 22;9(6):e04238.
doi: 10.1002/ccr3.4238. eCollection 2021 Jun.

Transient disappearance of CD19+/CD5+ B-lymphocyte clone in peripheral blood in a patient with CLL during SARS-CoV-2-related mild disease

Remo Barnabei  1 , Giulio Di Michele  1 , Antonio Cellini  2 , Gianfranco Amicosante  3 , Mariagrazia Perilli  3 , Pierangelo Bellio  3 , Alessandra Piccirilli  3 , Giuseppe Celenza  3
Affiliations
Case Reports

Transient disappearance of CD19+/CD5+ B-lymphocyte clone in peripheral blood in a patient with CLL during SARS-CoV-2-related mild disease

Remo Barnabei et al. Clin Case Rep. .

Abstract

Although lymphopenia is currently considered a good predictor for the prognosis of COVID-19, it must be critically evaluated in patients with CLL, where other clinical markers should be considered to define the prognosis and treatment.

Keywords: CD19+/CD5+ clone; SARS‐CoV‐2; lymphocytic leukemia.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

FIGURE 1
FIGURE 1
Aligned time‐course plots of significative hematological parameters (leukocytes count and lymphocytes percentage) and inflammation markers (C‐reactive protein and ferritin) recorded from hospital admission. Dashed lines represent the upper limit of the reference ranges
See this image and copyright information in PMC

References

    1. Jin XH, Zheng KI, Pan KH, Xie YP, Zheng MH. COVID‐19 in a patient with chronic lymphocytic leukaemia. Lancet Haematol. 2020;7(4):e351‐e352. 10.1016/S2352-3026(20)30074-0 - DOI - PMC - PubMed
    1. Paneesha S, Pratt G, Parry H, Moss P. Covid‐19 infection in therapy‐naive patients with B‐cell chronic lymphocytic leukemia. Leuk Res. 2020;93:106366. 10.1016/j.leukres.2020.106366 - DOI - PMC - PubMed
    1. Cuneo A, Scarfo L, Reda G, et al. Chronic lymphocytic leukemia management in Italy during the Covid‐19 pandemic: a campus CLL report. Blood. 2020;136(6):763‐766. 10.1182/blood.2020006854 - DOI - PMC - PubMed
    1. Mato AR, Roeker LE, Lamanna N, et al. Outcomes of Covid‐19 in patients with CLL: a multicenter international experience. Blood. 2020;136(10):1134‐1143. 10.1182/blood.2020006965 - DOI - PMC - PubMed
    1. Abid MB, Mughal M, Abid MA. Coronavirus disease 2019 (COVID‐19) and immune‐engaging cancer treatment. JAMA Oncol. 2020;6(10):1529‐1530. 10.1001/jamaoncol.2020.2367 - DOI - PubMed

Publication types

LinkOut - more resources